Alan X Xiang

This inventor holds 19 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in MNK Inhibitors. Top assignees: Effector Therapeutics, Inc., Anadys Pharmaceuticals, Inc., Sjp Biotec Gmbh. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan X Xiang. Retrieved from https://idiyas.com/inventor/alan-x-xiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 7)

% Patents Active = 68.4

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 93(Granted Patents)

Location History:

Chula Vista, CA (US) (2008)
San Diego, CA (US) (2009 - 2014)
Irvine, CA (US) (2016 - 2024)

Company Filing History:

10 out of 22

Effector Therapeutics, Inc.

patents

8 out of 51

Anadys Pharmaceuticals, Inc.

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

MNK Inhibitors

eIF4A Compounds

Crystalline Forms

Benzimidazole

Indole Inhibitors

3H-Oxazolo Compounds

Prodrugs

Nucleosides

Anticancer Agents

Pharmaceutical Chemistry

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747249 - EIF4A-inhibiting compounds and methods related thereto (2026-09-29),

2. 11952375 - Crystalline forms of Mnk inhibitors (2024-04-09),

3. 11440917 - EIF4A-inhibiting compounds and methods related thereto (2022-09-13),

4. 11286268 - EIF4E-inhibiting compounds and methods (2022-03-29),

5. 11130757 - Crystalline forms of MNK inhibitors (2021-09-28),

6. 10793551 - Benzimidazole-indole inhibitors of Mnk1 and Mnk2 (2020-10-06),

7. 10577378 - EIF4A-inhibiting compounds and methods related thereto (2020-03-03),

8. 9957277 - eIF4A-inhibiting compounds and methods related thereto (2018-05-01),

9. 9814718 - MNK inhibitors and methods related thereto (2017-11-14),

10. 9669031 - MNK inhibitors and methods related thereto (2017-06-06),

11. 9382248 - Mnk inhibitors and methods related thereto (2016-07-05),

12. 8883758 - 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof (2014-11-11),

13. 8097718 - [object Object] (2012-01-17),

14. 7943759 - 3-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof (2011-05-17),

15. 7709448 - [object Object] (2010-05-04),

Title: The Innovative Journey of Alan X Xiang

Introduction: Alan X Xiang, a visionary inventor based in Irvine, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Alan X Xiang's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive diagnostics, and a sustainable energy solution for urban environments.

Career Highlights: With a career spanning over two decades, Alan X Xiang has established himself as a leading figure in the tech industry. He has held key positions in renowned tech companies, where he spearheaded research and development projects that have shaped the future of technology.

Collaborations: Alan X Xiang is known for his collaborative spirit, having worked with top researchers, engineers, and scientists from around the world. His ability to bring together diverse teams has led to the successful implementation of innovative ideas and solutions.

Conclusion: Alan X Xiang's passion for innovation and his relentless drive to push the boundaries of technology continue to inspire the next generation of inventors. His remarkable achievements solidify his legacy as a true pioneer in the world of inventions.

Profile summary based on public USPTO records.